Post-Marketing Surveillance (PMS) Study to Evaluate Safety and Efficacy of Zeldox Capsule.

Trial Profile

Post-Marketing Surveillance (PMS) Study to Evaluate Safety and Efficacy of Zeldox Capsule.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2010

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Bipolar disorders; Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 03 Mar 2010 Actual patient number (21) added as reported by ClinicalTrials.gov.
    • 03 Mar 2010 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
    • 03 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top